Chiesi Group, a European pharmaceutical company, has signed through its UK affiliate Chiesi Ltd a definitive agreement with Sunstone Capital to acquire Zymenex, a biopharmaceutical group focused on research and development of biologic therapeutics for the treatment of rare and life threatening genetic diseases. Terms of the transaction have
Aquiline Capital Partners has made an investment, through affiliates, in Tourmalet Advisors, an alternative investment manager based in Fairfield, Connecticut. Tourmalet, led by chief executive officer Michael Corasaniti, was founded in October 2009 and has a track record of managing, investing, structuring and trading distressed residential mortgage assets. The
Qualcomm is to sell Omnitracs, its North and Latin American transportation and logistics business, to Vista Equity Partners, a US-based private equity firm. Subject to the terms and conditions of the definitive agreement, Vista will purchase Omnitracs for USD800m in cash. "In the late 1980s, Qualcomm pioneered the
Keating Capital, a pre-IPO investor and business development company, has made an additional USD1m convertible note investment in SilkRoad, an existing portfolio company. Keating Capital’s investment is part of a USD16m growth financing round completed by SilkRoad. Other participants in the financing include Foundation Capital, Intel Capital, Azure
Private equity firm Thoma Bravo has completed its acquisition of Keynote Systems, a provider of internet and mobile cloud testing and monitoring, for USD20 per share or approximately USD395m. With the transaction completed, Keynote’s stock will cease trading on the Nasdaq under the ticker symbol KEYN. Keynote will remain
TagMan, a tag management system, marketing data and marketing attribution provider, has received USD5m in new funding. Existing investors Greycroft Partners and iNovia Capital led the financing, and Silicon Valley Bank also injected capital. TagMan plans to use the awarded funds to ramp up growth of its 300-strong global
MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, has raised USD25m in series B financing. Led by BVCF, a private equity and growth fund specialising in the life sciences industry, the round also includes existing investors Morningside Group and Devon Park Bioventures. Proceeds from the series B financing
EQT Infrastructure II has completed the refinancing of Synagro Technologies under a comprehensive plan of reorganisation approved by the court with the full support of the company’s creditors via the Chapter 11 process. Synagro is an organic residuals management provider in the US. Through working constructively with its creditors
Private equity firm Levine Leichtman Capital Partners has partnered with management to complete a growth capital investment in Edison, New Jersey-based SFERRA Fine Linens. SFERRA, founded in 1891, designs and produces branded, Italian luxury linen products of the highest quality for luxury retailers and hundreds of specialty boutiques. The
European private equity firm Cinven has reached an agreement to acquire a majority stake in Heidelberger Leben, a provider of retirement and life insurance products in Germany. Heidelberger Leben will become a consolidation platform for life insurance portfolios in Germany. It is being acquired from Lloyds Banking Group for
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
